Advertisement
Screener

ASTRAZENECA PLC (AZN) Scorecard

2.8 / 5 stars · 68/120 Roast Me

19/120 0.8 / 5 stars All 120 Win/Lose results shown below

AZN Roast Me summary

ASTRAZENECA PLC (AZN). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

  • 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
  • 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
  • 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 25 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q20/3 LoseAZN / S&P
-3.85% / 15.20%
LoseAZN / S&P
AZN unavailable / 15.00%
LoseAZN / S&P
AZN unavailable / 50.40%
2026-Q11/3 WinAZN / S&P
8.38% / -4.33%
LoseAZN / S&P
AZN unavailable / 11.30%
LoseAZN / S&P
AZN unavailable / 27.70%
2025-Q41/3 WinAZN / S&P
19.83% / 2.65%
LoseAZN / S&P
AZN unavailable / 9.00%
LoseAZN / S&P
AZN unavailable / 13.40%
2025-Q31/3 WinAZN / S&P
10.55% / 8.12%
LoseAZN / S&P
AZN unavailable / 4.61%
LoseAZN / S&P
AZN unavailable / 13.45%
2025-Q20/3 LoseAZN / S&P
-4.93% / 10.94%
LoseAZN / S&P
AZN unavailable / 4.83%
LoseAZN / S&P
AZN unavailable / 10.63%
2025-Q11/3 WinAZN / S&P
13.78% / -4.27%
LoseAZN / S&P
AZN unavailable / 4.98%
LoseAZN / S&P
AZN unavailable / 10.57%
2024-Q40/3 LoseAZN / S&P
-15.90% / 2.41%
LoseAZN / S&P
AZN unavailable / 5.25%
LoseAZN / S&P
AZN unavailable / 6.15%
2024-Q30/3 LoseAZN / S&P
0.51% / 5.89%
LoseAZN / S&P
AZN unavailable / 5.89%
LoseAZN / S&P
AZN unavailable / 6.11%
2024-Q21/3 WinAZN / S&P
15.11% / 4.28%
LoseAZN / S&P
AZN unavailable / 5.38%
LoseAZN / S&P
AZN unavailable / 5.12%
2024-Q10/3 LoseAZN / S&P
2.14% / 10.56%
LoseAZN / S&P
AZN unavailable / 5.71%
LoseAZN / S&P
AZN unavailable / 5.59%
2023-Q40/3 LoseAZN / S&P
-0.55% / 11.69%
LoseAZN / S&P
AZN unavailable / 6.81%
LoseAZN / S&P
AZN unavailable / 7.78%
2023-Q30/3 LoseAZN / S&P
-4.76% / -3.27%
LoseAZN / S&P
AZN unavailable / 7.52%
LoseAZN / S&P
AZN unavailable / -5.03%
2023-Q20/3 LoseAZN / S&P
3.11% / 8.74%
LoseAZN / S&P
AZN unavailable / 9.50%
LoseAZN / S&P
AZN unavailable / -8.57%
2023-Q10/3 LoseAZN / S&P
3.86% / 7.50%
LoseAZN / S&P
AZN unavailable / 10.77%
LoseAZN / S&P
AZN unavailable / -15.69%
2022-Q41/3 WinAZN / S&P
23.63% / 7.56%
LoseAZN / S&P
AZN unavailable / 11.88%
LoseAZN / S&P
AZN unavailable / -17.99%
2022-Q30/3 LoseAZN / S&P
-16.41% / -4.88%
LoseAZN / S&P
AZN unavailable / 13.47%
LoseAZN / S&P
AZN unavailable / -1.41%
2022-Q21/3 WinAZN / S&P
-0.41% / -16.10%
LoseAZN / S&P
AZN unavailable / 13.71%
LoseAZN / S&P
AZN unavailable / 11.04%
2022-Q11/3 WinAZN / S&P
15.77% / -4.60%
LoseAZN / S&P
AZN unavailable / 15.97%
LoseAZN / S&P
AZN unavailable / 42.23%
2021-Q40/3 LoseAZN / S&P
-3.01% / 11.03%
LoseAZN / S&P
AZN unavailable / 15.00%
LoseAZN / S&P
AZN unavailable / 96.40%
2021-Q31/3 WinAZN / S&P
1.07% / 0.58%
LoseAZN / S&P
AZN unavailable / 10.77%
LoseAZN / S&P
AZN unavailable / 69.42%
2021-Q21/3 WinAZN / S&P
20.47% / 8.55%
LoseAZN / S&P
AZN unavailable / 6.58%
LoseAZN / S&P
AZN unavailable / 51.81%
2021-Q10/3 LoseAZN / S&P
1.38% / 6.17%
LoseAZN / S&P
AZN unavailable / -1.06%
LoseAZN / S&P
AZN unavailable / 7.39%
2020-Q40/3 LoseAZN / S&P
-8.78% / 12.15%
LoseAZN / S&P
AZN unavailable / -3.72%
LoseAZN / S&P
AZN unavailable / -33.42%
2020-Q30/3 LoseAZN / S&P
4.44% / 8.93%
LoseAZN / S&P
AZN unavailable / -2.04%
LoseAZN / S&P
AZN unavailable / -27.10%
2020-Q20/3 LoseAZN / S&P
18.43% / 20.54%
LoseAZN / S&P
AZN unavailable / -0.46%
LoseAZN / S&P
AZN unavailable / -27.11%
2020-Q11/3 WinAZN / S&P
-8.60% / -19.60%
LoseAZN / S&P
AZN unavailable / 3.47%
LoseAZN / S&P
AZN unavailable / -14.75%
2019-Q41/3 WinAZN / S&P
11.87% / 9.07%
LoseAZN / S&P
AZN unavailable / 5.36%
LoseAZN / S&P
AZN unavailable / 2.99%
2019-Q31/3 WinAZN / S&P
9.09% / 1.70%
LoseAZN / S&P
AZN unavailable / 5.02%
LoseAZN / S&P
AZN unavailable / 0.21%
2019-Q20/3 LoseAZN / S&P
2.10% / 4.30%
LoseAZN / S&P
AZN unavailable / 6.64%
LoseAZN / S&P
AZN unavailable / 8.65%
2019-Q10/3 LoseAZN / S&P
8.89% / 13.65%
LoseAZN / S&P
AZN unavailable / 8.12%
LoseAZN / S&P
AZN unavailable / 14.29%
2018-Q41/3 WinAZN / S&P
-4.02% / -13.52%
LoseAZN / S&P
AZN unavailable / 9.05%
LoseAZN / S&P
AZN unavailable / 18.23%
2018-Q31/3 WinAZN / S&P
14.01% / 7.71%
LoseAZN / S&P
AZN unavailable / 10.21%
LoseAZN / S&P
AZN unavailable / 19.06%
2018-Q20/3 LoseAZN / S&P
0.40% / 3.43%
LoseAZN / S&P
AZN unavailable / 9.03%
LoseAZN / S&P
AZN unavailable / 14.46%
2018-Q11/3 WinAZN / S&P
3.64% / -0.76%
LoseAZN / S&P
AZN unavailable / 7.68%
LoseAZN / S&P
AZN unavailable / 12.46%
2017-Q40/3 LoseAZN / S&P
2.42% / 6.64%
LoseAZN / S&P
AZN unavailable / 7.03%
LoseAZN / S&P
AZN unavailable / 13.82%
2017-Q30/3 LoseAZN / S&P
0.91% / 4.48%
LoseAZN / S&P
AZN unavailable / 5.68%
LoseAZN / S&P
AZN unavailable / 17.57%
2017-Q21/3 WinAZN / S&P
9.47% / 3.09%
LoseAZN / S&P
AZN unavailable / 4.83%
LoseAZN / S&P
AZN unavailable / 17.74%
2017-Q11/3 WinAZN / S&P
17.76% / 6.07%
LoseAZN / S&P
AZN unavailable / 3.67%
LoseAZN / S&P
AZN unavailable / 13.32%
2016-Q40/3 LoseAZN / S&P
-16.86% / 3.82%
LoseAZN / S&P
AZN unavailable / 2.09%
LoseAZN / S&P
AZN unavailable / 7.05%
2016-Q31/3 WinAZN / S&P
10.30% / 3.85%
LoseAZN / S&P
AZN unavailable / 0.20%
LoseAZN / S&P
AZN unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-28

MetricAZN total returnS&P 500 Total Return Index
Total return2.87%20.78%
Annualized return2.87%20.78%

5Y · 2021-09-01 to 2026-08-28

MetricAZN total returnS&P 500 Total Return Index
Total return52.68%83.14%
Annualized return8.83%12.86%

10Y · 2016-09-01 to 2026-08-28

MetricAZN total returnS&P 500 Total Return Index
Total return227.80%319.30%
Annualized return12.61%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-25.